Aurore Devocelle

Villejuif, 94800, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma.

Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma.

Journal: Cells
Published: April 14, 2026

The epigenetic regulator SETDB1 as a key component of cancer stem cells and drug resistance in primary liver cancer.

The epigenetic regulator SETDB1 as a key component of cancer stem cells and drug resistance in primary liver cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: September 22, 2025

IL-15 Prevents Renal Fibrosis by Inhibiting Collagen Synthesis: A New Pathway in Chronic Kidney Disease?

IL-15 Prevents Renal Fibrosis by Inhibiting Collagen Synthesis: A New Pathway in Chronic Kidney Disease?

Journal: International journal of molecular sciences
Published: September 24, 2021

BMAL1 Knockdown Leans Epithelial-Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells.

BMAL1 Knockdown Leans Epithelial-Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells.

Journal: International journal of molecular sciences
Published: April 13, 2021

BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways.

BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways.

Journal: Aging
Published: October 02, 2019

Inhibition of TGF-β1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-β1-Induced EMT in Renal Fibrosis.

Inhibition of TGF-β1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-β1-Induced EMT in Renal Fibrosis.

Journal: International journal of cell biology
Published: September 06, 2018

IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process.

IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process.

Journal: Oncotarget
Published: July 13, 2016

Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions.

Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions.

Journal: Neoplasia (New York, N.Y.)
Published: November 05, 2014

Cannabinoid receptor 1 is a major mediator of renal fibrosis.

Cannabinoid receptor 1 is a major mediator of renal fibrosis.

Journal: Kidney international
Published: July 03, 2014

Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.

Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.

Journal: Journal of the National Cancer Institute
Published: November 02, 2011
Showing 1-10 of 10

Last Updated: 09/26/2026